Clincosm LogoSign in Get a demo

DiffHésiVac: Difference Between Patient Vaccine Hesitancy and Perception by Their Family Physician of Their Vaccine Hesitancy

Sponsor
University Hospital, Grenoble (Other)
Overall Status
Unknown status
CT.gov ID
NCT04313816
Collaborator
(none)
400
Enrollment
1
Location
10.5
Anticipated Duration (Months)
37.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The investigators will ask to a patient and his/her family physician to complete in parallel a brief questionnaire at the beginning of the consultation:

  • for the patient: self-evaluation of his/her vaccine hesitancy (with a 0-100 scale)

  • for the physician: evaluation of this patient vaccine hesitancy (on the same 0-100 scale) Each of these 2 questionnaires should be filled blindly from the other.

Condition or Disease Intervention/Treatment Phase
  • Other: questionnaire

Detailed Description

The investigators will ask to a patient and his/her family physician to complete in parallel a brief questionnaire at the beginning of the consultation:

  • for the patient: self-evaluation of his/her vaccine hesitancy (with a 0-100 scale)

  • for the physician: evaluation of this patient vaccine hesitancy (on the same 0-100 scale) Each of these 2 questionnaires should be filled blindly from the other.

The investigators will recruit 400 to 500 patients in 20 medical practices of general practioners.

Study Design

Study Type:
Observational
Anticipated Enrollment :
400 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Difference Between Patient Vaccine Hesitancy and Perception by Their Family Physician of Their Vaccine Hesitancy
Actual Study Start Date :
Feb 14, 2020
Anticipated Primary Completion Date :
Dec 31, 2020
Anticipated Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
unique group

patients visiting their family physician

Other: questionnaire
no intervention at all apart from filling a brief questionnaire
Other Names:
  • no intervention at all apart from filling a brief questionnaire

    		•

    Outcome Measures

    Primary Outcome Measures

    1. difference between patient's vaccine hesitancy and perception by his/her family physician of his/her vaccine hesitancy. [one day]

      Each participant will evaluate hi/her vaccine hesitancy on a 0-100 scale; his/her family physician will also evaluate the vaccine hesitancy of this participant on the same 0-100 scale. The outcome 1 is the difference between patient's vaccine hesitancy and perception by his/her family physician of his/her vaccine hesitancy (on this 0-100 scale). These are arbitrary units.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • visiting the family physician

    • accepting the study after information

    Exclusion Criteria:
    • none apart from the reverse of inclusion criteria

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 EPAULARD Grenoble France 38000

    Sponsors and Collaborators

    • University Hospital, Grenoble

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Grenoble
    ClinicalTrials.gov Identifier:
    NCT04313816
    Other Study ID Numbers:
    • 38RC19.288
    • 2019-A02487-50
    First Posted:
    Mar 18, 2020
    Last Update Posted:
    Mar 18, 2020
    Last Verified:
    Mar 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Mar 18, 2020